20 results
8-K
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
/ toxicology and clinical research services (in JV with PPD) Strong history of innovation 2012 Established WAVE Life Sciences (Nasdaq:WVE) Early 2000s
10-K
xgreuzz zvuu
10 Mar 20
Annual report
4:20pm
10-Q
aj84q gqswpy0xart0k
12 Nov 19
Quarterly report
4:31pm
424B4
nbtiif ynkx
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
op8af eov16m
3 Sep 19
IPO registration (amended)
6:12am
S-1
x3yofk vu
16 Aug 19
IPO registration
5:15pm
DRS/A
rjmt6rqdq3e7
2 Aug 19
Draft registration statement (amended)
12:00am
DRS
cb25sgcoh
21 Jun 19
Draft registration statement
12:00am
- Prev
- 1
- Next